Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFNγ signaling-Reference-Cited by-同舟云学术

Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFNγ signaling

Published:2017-06-03 Issue:6 Volume:6 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Penafuerte Claudia¹,Feldhammer Matthew¹²,Mills John R.²,Vinette Valerie¹²,Pike Kelly A.¹,Hall Anita¹³,Migon Eva¹,Karsenty Gerard⁴,Pelletier Jerry¹²,Zogopoulos George¹³,Tremblay Michel L.¹²

Affiliation:

1. Goodman Cancer Research Centre, McGill University, Montreal, QC, Canada

2. Department of Biochemistry, McGill University, Montreal, QC, Canada

3. McGill University Health Centre-Research Institute, MUHC-RI, Montreal, QC, Canada

4. Columbia University, New York, NY, USA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1321185

Reference40 articles.

1. Innate immune regulation by STAT-mediated transcriptional mechanisms

2. TYK2 and JAK2 Are Substrates of Protein-tyrosine Phosphatase 1B

3. Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation

4. Protein Tyrosine Phosphatase 1B Is a Regulator of the Interleukin-10–Induced Transcriptional Program in Macrophages

5. The T Cell Protein Tyrosine Phosphatase Is a Negative Regulator of Janus Family Kinases 1 and 3

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Developments in the Role of Protein Tyrosine Phosphatase 1B (PTP1B) as a Regulator of Immune Cell Signalling in Health and Disease;International Journal of Molecular Sciences;2024-06-29

2. Site-Specifically Modified Peptide Inhibitors of Protein Tyrosine Phosphatase 1B and T-Cell Protein Tyrosine Phosphatase with Enhanced Stability and Improved In Vivo Long-Acting Activity;ACS Pharmacology & Translational Science;2024-04-24

3. Immunotherapeutic implications of negative regulation by protein tyrosine phosphatases in T cells: the emerging cases of PTP1B and TCPTP;Frontiers in Medicine;2024-04-19

4. Small molecule inhibitors for cancer immunotherapy and associated biomarkers – the current status;Frontiers in Immunology;2023-10-31

5. STATs signaling pathways in dendritic cells: As potential therapeutic targets?;International Reviews of Immunology;2023-10-27